Closed call for evidence

Synthetic cathinones

Summary

The Novel Psychoactive Substances Committee (NPSC) is seeking evidence for its review of the evidence of the misuse and harms of synthetic cathinones in the UK.

This call for evidence ran from
to

Call for evidence description

Completing the questionnaire

Although your expertise may be better suited to only a subset of the following questions, it would be helpful if you could consider every question in the questionnaire.

Where possible, please provide supporting evidence and references in your response. The ACMD considers a wide range of evidence as part of its advice, including published literature, statistics, data from UK organisations and expert and stakeholder opinions.

How we will use your information

Respondents should note that evidence submitted will inform the development of recommendations from the ACMD and could ultimately be published. However, in the interest of confidentiality and protecting commercial interests, any information submitted will be non-attributable.

All data submitted in response to this call for evidence will be protected by the ACMD Secretariat in accordance with the UK General Data Protection Regulation (UK GDPR). Furthermore, Section 43(1) of the Freedom of Information Act provides an exemption for information which is a trade secret, whilst Section 43(2) exempts information whose disclosure would, or would be likely to, prejudice the commercial interests of any person (an individual, a company, the public authority itself or any other legal entity).

Documents

Call for evidence letter

Updates to this page

Published 20 May 2024

Sign up for emails or print this page